BAYSHORE PHARMACEUTICALS
BAYSHORE PHARMACEUTICALS appears in FDA public data with 2 recalls, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-1544-2020, Class II) was initiated on August 19, 2020.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1544-2020 | Class II | Metformin Hydrochloride Extended-Release Tablets USP, 750 mg 100 Tablets Rx Only Manufactured by: Be | August 19, 2020 |
| D-1543-2020 | Class II | Metformin Hydrochloride Extended-Release Tablets USP, 500 mg 1000 Tablets Rx Only Manufactured by: B | August 19, 2020 |